Ingevity CORP 8-K filings
Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced its second quarter 2026 financial results, showcasing a significant year-over-year improvement in net income and adjusted EBITDA, leading to an increased full-year financial outlook.
NYSE
NGVT
Ingevity CORPIngevity Corporation has appointed Ryan Cotterman as its new Vice President and Chief Accounting Officer, effective June 22, 2026.
NYSE
NGVT
Ingevity CORPIngevity announced its first quarter 2026 financial results, with net sales up 4% to $258.0 million, driven by pricing actions and favorable foreign exchange, while navigating divestitures and legal settlements.
NYSE
NGVT
Ingevity CORPIngevity Corporation's annual stockholder meeting saw approval for an amendment to its 2025 Omnibus Incentive Plan, increasing available shares by 580,000.
NYSE
NGVT
Ingevity CORPIngevity Corporation has finalized the divestiture of its Ozark Materials road markings business to PPG Industries for approximately $65 million in cash.
NYSE
NGVT
Ingevity CORPIngevity amended and restated its credit facility, cutting total commitments to $750 million and extending the revolver maturity to March 26, 2031, while repaying $512.1 million of outstanding borrowings.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced strong full-year 2025 financial results, including higher adjusted earnings and robust cash flow, alongside significant portfolio optimization actions and a positive 2026 outlook.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced that two founding directors will not seek re-election at the 2026 Annual Meeting, leading to a reduction in board size from 11 to 9 members.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced the completion of the sale of its North Charleston crude tall oil refinery and most of its Industrial Specialties product line for $110 million cash plus potential contingent consideration.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced significant executive leadership transitions, including a new CFO and SVP of Operations, as it completes its strategic portfolio review.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced the completion of its portfolio review, initiating exploration of strategic alternatives for its Advanced Polymer Technologies segment and Road Markings business, alongside over $30 million in Q4 2025 stock repurchases.
NYSE
NGVT
Ingevity CORPIngevity Corporation has reclassified its industrial specialties product line and CTO refinery as discontinued operations, providing recast financials to reflect a strategic shift.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced preliminary third quarter 2025 financial results, including a 14% increase in Total Adjusted EBITDA, strong free cash flow, and a revised full-year guidance reflecting portfolio optimization and segment-specific challenges.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced the appointment of Ruth Castillo as Senior Vice President and President of its Performance Materials segment, effective November 10, 2025.
NYSE
NGVT
Ingevity CORPIngevity Corporation announced an agreement to sell its North Charleston crude tall oil refinery and most of its Industrial Specialties product line to Mainstream Pine Products for $110 million in cash, plus potential contingent consideration.
NYSE
NGVT
Ingevity CORPIngevity Corporation reported a net loss in Q2 2025 due to a significant goodwill impairment, but saw strong growth in adjusted earnings and raised its full-year adjusted EBITDA guidance.
NYSE
NGVT
Ingevity CORP8-K: Ingevity Announces Departure of Performance Materials President, Initiates Search for Successor
Ingevity Corporation announced the departure of S. Edward Woodcock, Executive Vice President and President of Performance Materials, effective July 1, 2025, with an interim leadership plan in place and a search for his successor underway.
NYSE
NGVT
Ingevity CORPIngevity's Q1 2025 results show a 17% decrease in net sales but a 23% increase in adjusted EBITDA, driven by strategic repositioning in Performance Chemicals.
NYSE
NGVT
Ingevity CORPIngevity Corporation announces the expansion of its Board of Directors, the election of David H. Li and F. David Segal as new members, the election of Bruce D. Hoechner as Chair, and the approval of the 2025 Omnibus Incentive Plan.
NYSE
NGVT
Ingevity CORPIngevity Corporation and Vision One Fund, LP enter into a cooperation agreement, resulting in the appointment of F. David Segal to Ingevity's Board of Directors and other governance arrangements.
NYSE
NGVT
Ingevity CORPIngevity Corporation has appointed David H. Li as its new President and CEO, succeeding interim CEO Luis Fernandez-Moreno, effective April 7, 2025.
NYSE
NGVT
Ingevity CORPIngevity's Q4 results show a sales decrease due to strategic repositioning, but adjusted EBITDA improved; the company also announced 2025 guidance.
NYSE
NGVT
Ingevity CORPIngevity is exploring strategic options for its Performance Chemicals Industrial Specialties product line, including a potential divestiture, while also releasing preliminary 2024 financial results.
NYSE
NGVT
Ingevity CORPIngevity Corporation has increased its board size and appointed J. Kevin Willis, CFO of Ashland Inc., as a new independent director.
NYSE
NGVT
Ingevity CORPIngevity's third quarter results show a net loss due to significant restructuring charges and contract termination fees, despite some positive performance in specific segments.
NYSE
NGVT
Ingevity CORPIngevity Corporation's Board of Directors has approved and adopted amended and restated bylaws, revising procedures for stockholder nominations and proposals.
NYSE
NGVT
Ingevity CORPIngevity Corporation has announced the departure of its CEO, John Fortson, and the appointment of Luis Fernandez-Moreno as interim CEO, effective October 2, 2024.
NYSE
NGVT
Ingevity CORPIngevity Corporation reported a net loss of $283.7 million for the second quarter of 2024, primarily due to a non-cash goodwill impairment charge in its Performance Chemicals segment, while also announcing restructuring actions and revised full-year guidance.
NYSE
NGVT
Ingevity CORPIngevity Corporation will close its Crossett, Arkansas plant and consolidate operations to its North Charleston facility, aiming for significant cost savings and improved profitability in its Performance Chemicals segment.
NYSE
NGVT
Ingevity CORPIngevity Corporation has agreed to pay Georgia-Pacific $100 million to terminate a long-term crude tall oil supply agreement, aiming for greater flexibility in its Performance Chemicals business.